Basic Information
| RNALocate ID: | RLID:11001840 |
| RNA Symbol: | hsa-miR-191-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-191 |
| RNA ID: | miRBase:MIMAT0000440 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 24009880 |
| Tissue/Cell Line: | Human mast cell line (HMC-1) |
| Method: | Microarray |
| Description: | In the exosomes, 116 microRNAs were identified and 134 microRNAs were identified in the donor HMC-1 cells (Fig. 3a and 3b, Table I and Additional Information, Table S16). Data are collected from Table 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001799 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01001800 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001801 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001802 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001803 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001804 | Nucleolus | HeLa cells | 23940654 |
| RLID:01001805 | Nucleolus | Breast adenocarcinoma cells (MCF-7) | 24918059 |
| RLID:11001832 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
| RLID:11001833 | Exosome | Human cervical cancer cell line (HeLa) | 25760330 |
| RLID:11001834 | Exosome | Plasma | 19289371 |
| RLID:11001835 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11001836 | Exosome | B cell line (Raji)|Jurkat-derived T cell line (J77cl20) | 21505438 |
| RLID:11001837 | Exosome | Breast milk | 22211110 |
| RLID:11001838 | Exosome | Brain tissue | 23382797 |
| RLID:11001839 | Exosome | Plasma | 23663360 |
| RLID:11001841 | Exosome | Serum|Urine | 25135963 |
| RLID:11001842 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001843 | Microvesicle | Plasma | 23077538 |
| RLID:11001844 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001845 | Microvesicle | Follicular fluid | 23666971 |
| RLID:11001846 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11000088 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000368 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-191-5p | Splenic marginal zone lymphoma | MNDR-E-MI-22530 |
| MNDR | hsa-miR-191-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-22531 |
| MNDR | hsa-miR-191-5p | Oral squamous cell carcinoma | MNDR-E-MI-22532 |
| MNDR | hsa-miR-191-5p | Medulloblastoma | MNDR-E-MI-22533 |
| MNDR | hsa-miR-191-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-22534 |
| MNDR | hsa-miR-191-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-22535 |
| MNDR | hsa-miR-191-5p | Lymphoma | MNDR-E-MI-22536 |
| MNDR | hsa-miR-191-5p | Lymphoma non-hodgkin | MNDR-E-MI-22537 |
| MNDR | hsa-miR-191-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-22538 |
| MNDR | hsa-miR-191-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-22539 |
| MNDR | hsa-miR-191-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-22540 |
| MNDR | hsa-miR-191-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-22541 |
| MNDR | hsa-miR-191-5p | Breast cancer luminal | MNDR-E-MI-22542 |
| MNDR | hsa-miR-191-5p | Niemann-pick disease type c | MNDR-E-MI-22543 |
| MNDR | hsa-miR-191-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-22544 |
| MNDR | hsa-miR-191-5p | Prostate cancer | MNDR-E-MI-22545 |
| MNDR | hsa-miR-191-5p | Gastric cancer | MNDR-E-MI-22546 |
| MNDR | hsa-miR-191-5p | Alzheimer disease | MNDR-E-MI-22547 |
| MNDR | hsa-miR-191-5p | Dysautonomia familial | MNDR-E-MI-22548 |
| MNDR | hsa-miR-191-5p | Myotonic dystrophy | MNDR-E-MI-22549 |
| MNDR | hsa-miR-191-5p | Head and neck cancer | MNDR-E-MI-22550 |
| MNDR | hsa-miR-191-5p | Graves disease | MNDR-E-MI-22551 |
| MNDR | hsa-miR-191-5p | Cardiovascular disease | MNDR-E-MI-22552 |
| MNDR | hsa-miR-191-5p | Carotid stenosis | MNDR-E-MI-22553 |
| MNDR | hsa-miR-191-5p | Lung cancer | MNDR-E-MI-22554 |
| MNDR | hsa-miR-191-5p | Down syndrome | MNDR-E-MI-22555 |
| MNDR | hsa-miR-191-5p | Parkinson disease | MNDR-E-MI-22556 |
| MNDR | hsa-miR-191-5p | Niemann-pick disease | MNDR-E-MI-22557 |
| MNDR | hsa-miR-191-5p | Cognitive dysfunction | MNDR-E-MI-22558 |
| MNDR | hsa-miR-191-5p | Breast cancer | MNDR-E-MI-22559 |
| MNDR | hsa-miR-191-5p | Pituitary neoplasms | MNDR-E-MI-22560 |
| MNDR | hsa-miR-191-5p | Pancreatic cancer | MNDR-E-MI-22561 |
| MNDR | hsa-miR-191-5p | Melanoma | MNDR-E-MI-22562 |
| MNDR | hsa-miR-191-5p | Lesch-nyhan syndrome | MNDR-E-MI-22563 |
| MNDR | hsa-miR-191-5p | Colon cancer | MNDR-E-MI-22564 |
| MNDR | hsa-miR-191-5p | Ischemic attack transient | MNDR-E-MI-22565 |
| MNDR | hsa-miR-191-5p | Colon adenocarcinoma | MNDR-E-MI-22566 |
| MNDR | hsa-miR-191-5p | Multiple sclerosis | MNDR-E-MI-22567 |
| MNDR | hsa-miR-191-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-22568 |
| MNDR | hsa-miR-191-5p | Familial ovarian cancer | MNDR-E-MI-22569 |
| MNDR | hsa-miR-191-5p | Prostate adenocarcinoma | MNDR-E-MI-22570 |
| MNDR | hsa-miR-191-5p | Kidney cancer | MNDR-E-MI-22571 |
| MNDR | hsa-miR-191-5p | Carcinoma ductal breast | MNDR-E-MI-22572 |
| MNDR | hsa-miR-191-5p | Invasive ductal carcinoma | MNDR-E-MI-22573 |
| MNDR | hsa-miR-191-5p | Glioblastoma | MNDR-E-MI-22574 |
| MNDR | hsa-miR-191-5p | Glioma | MNDR-E-MI-22575 |
| MNDR | hsa-miR-191-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-22576 |
| MNDR | hsa-miR-191-5p | Chordoma | MNDR-E-MI-22577 |
| MNDR | hsa-miR-191-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-22578 |
| MNDR | hsa-miR-191-5p | Osteosarcoma | MNDR-E-MI-22579 |
| MNDR | hsa-miR-191-5p | Meningioma | MNDR-E-MI-22580 |
| MNDR | hsa-miR-191-5p | Liver cancer | MNDR-E-MI-22581 |
| MNDR | hsa-miR-191-5p | Cervical adenocarcinoma | MNDR-E-MI-22582 |
| MNDR | hsa-miR-191-5p | Gastric adenocarcinoma | MNDR-E-MI-22583 |
| MNDR | hsa-miR-191-5p | Pituitary adenoma | MNDR-E-MI-22584 |
| MNDR | hsa-miR-191-5p | Lung squamous cell carcinoma | MNDR-E-MI-22585 |
| MNDR | hsa-miR-191-5p | Lung adenocarcinoma | MNDR-E-MI-22586 |
| MNDR | hsa-miR-191-5p | Thyroid carcinoma | MNDR-E-MI-22587 |
| MNDR | hsa-miR-191-5p | Ovarian carcinoma | MNDR-E-MI-22588 |
| MNDR | hsa-miR-191-5p | Bladder urothelial carcinoma | MNDR-E-MI-22589 |
| MNDR | hsa-miR-191-5p | Pancreatic adenocarcinoma | MNDR-E-MI-22590 |
| MNDR | hsa-miR-191-5p | Carcinoma renal cell | MNDR-E-MI-22591 |
| MNDR | hsa-miR-191-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-22592 |
| MNDR | hsa-miR-191-5p | Renal clear cell carcinoma | MNDR-E-MI-22593 |
| MNDR | hsa-miR-191-5p | Biliary tract cancer | MNDR-E-MI-22594 |
| MNDR | hsa-miR-191-5p | Cholangiocarcinoma | MNDR-E-MI-22595 |
| MNDR | hsa-miR-191-5p | Esophageal cancer | MNDR-E-MI-22596 |
| MNDR | hsa-miR-191-5p | Lung small cell carcinoma | MNDR-E-MI-22597 |
| MNDR | hsa-miR-191-5p | Encephalopathy bovine spongiform | MNDR-E-MI-22598 |
| MNDR | hsa-miR-191-5p | Synovial sarcoma | MNDR-E-MI-22599 |
| MNDR | hsa-miR-191-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-22600 |
| MNDR | hsa-miR-191-5p | Myocardial infarction | MNDR-E-MI-22601 |
| MNDR | hsa-miR-191-5p | Encephalomyelitis | MNDR-E-MI-22602 |
| MNDR | hsa-miR-191-5p | Adenoma | MNDR-E-MI-22603 |
| MNDR | hsa-miR-191-5p | Breast invasive carcinoma | MNDR-E-MI-22604 |
| MNDR | hsa-miR-191-5p | Hepatocellular carcinoma | MNDR-E-MI-22605 |
| MNDR | hsa-miR-191-5p | Familiar ovarian carcinoma | MNDR-E-MI-22606 |
| MNDR | hsa-miR-191-5p | B-cell lymphoma | MNDR-E-MI-22607 |
| MNDR | hsa-miR-191-5p | Rheumatoid arthritis | MNDR-E-MI-22608 |
| MNDR | hsa-miR-191-5p | Retinoblastoma | MNDR-E-MI-22609 |
| MNDR | hsa-miR-191-5p | Barrett's adenocarcinoma | MNDR-E-MI-22610 |
| MNDR | hsa-miR-191-5p | Chronic fatigue syndrome | MNDR-E-MI-22611 |
| MNDR | hsa-miR-191-5p | Burkitt lymphoma | MNDR-E-MI-22612 |
| MNDR | hsa-miR-191-5p | Neuromyelitis optica | MNDR-E-MI-22613 |
| MNDR | hsa-miR-191-5p | Colorectal cancer | MNDR-E-MI-22614 |
| MNDR | hsa-miR-191-5p | Nasopharynx carcinoma | MNDR-E-MI-22615 |
| MNDR | hsa-miR-191-5p | Type 2 diabetes mellitus | MNDR-E-MI-22616 |
| MNDR | hsa-miR-191-5p | Multiple myeloma | MNDR-E-MI-22617 |
| MNDR | hsa-miR-191-5p | Acute lymphocytic leukemia | MNDR-E-MI-22618 |
| MNDR | hsa-miR-191-5p | Brain injuries traumatic | MNDR-E-MI-22619 |
| MNDR | hsa-miR-191-5p | Ependymoma | MNDR-E-MI-22620 |
| MNDR | hsa-miR-191-5p | Nasopharyngeal cancer | MNDR-E-MI-22621 |
| MNDR | hsa-miR-191-5p | Prostatic neoplasms | MNDR-E-MI-22622 |
| MNDR | hsa-miR-191-5p | Sleep deprivation | MNDR-E-MI-22623 |
| MNDR | hsa-miR-191-5p | Epstein-barr virus infections | MNDR-E-MI-22624 |
| MNDR | hsa-miR-191-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-22625 |
| MNDR | hsa-miR-191-5p | Venous thromboembolism | MNDR-E-MI-22626 |
| MNDR | hsa-miR-191-5p | Stroke lacunar | MNDR-E-MI-22627 |
| MNDR | hsa-miR-191-5p | Barrett's carcinogenesis | MNDR-E-MI-22628 |
| MNDR | hsa-miR-191-5p | Breast cancer her3+ negative | MNDR-E-MI-22629 |
| MNDR | hsa-miR-191-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-22630 |
| MNDR | hsa-miR-191-5p | Tubulovillous adenoma | MNDR-E-MI-22631 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | BASP1 | Homo sapiens | RR00211911 |
TOP